{
    "clinical_study": {
        "@rank": "132838", 
        "arm_group": {
            "arm_group_label": "Focused ultrasound treatment", 
            "arm_group_type": "Experimental", 
            "description": "Patients in this arm will receive fibroid treatment using the Mirabilis High-Intensity Focused Ultrasound Treatment System."
        }, 
        "brief_summary": {
            "textblock": "The Mirabilis High-Intensity Focused Ultrasound (HIFU) Treatment System delivers therapeutic\n      focused ultrasound energy to the uterus under integrated ultrasound imaging guidance to\n      offer non-invasive treatment for uterine fibroids.  The purpose of this clinical study is to\n      assess the initial safety and performance of the Mirabilis HIFU Treatment System for\n      transabdominal treatment of uterine fibroids in eligible women who are scheduled to undergo\n      hysterectomy following treatment with the device."
        }, 
        "brief_title": "Clinical Study of the Mirabilis High-Intensity Focused Ultrasound System for Non-Invasive Treatment of Uterine Fibroids", 
        "condition": "Uterine Fibroids (Leiomyomas)", 
        "condition_browse": {
            "mesh_term": [
                "Leiomyoma", 
                "Myofibroma"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Female\n\n          -  Age 18-55 years\n\n          -  Scheduled to undergo abdominal hysterectomy due to benign pathology including uterine\n             fibroids\n\n          -  Able and willing to provide informed consent\n\n        Exclusion Criteria:\n\n          -  Visible scar within the HIFU beam path that cannot be avoided\n\n          -  Known or suspected abdominal adhesions between the anterior uterine serosa and the\n             abdominal wall\n\n          -  Currently pregnant or desire to become pregnant in the future\n\n          -  Pelvic malignancy\n\n          -  Pelvic congenital malformation\n\n          -  Acute pelvic infection\n\n          -  Otherwise determined by a physician to be inappropriate for the study"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01946178", 
            "org_study_id": "No. 1006"
        }, 
        "intervention": {
            "arm_group_label": "Focused ultrasound treatment", 
            "description": "The intervention consists of a treatment session with the device, during which focused ultrasound energy is applied across the intact abdominal wall to ablate appropriately selected uterine fibroids under ultrasound imaging guidance.", 
            "intervention_name": "Mirabilis High-Intensity Focused Ultrasound Treatment System", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Uterine Fibroids", 
            "Leiomyomas", 
            "High-Intensity Focused Ultrasound Ablation", 
            "Ultrasonography"
        ], 
        "lastchanged_date": "March 24, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Ciudad de Mexico", 
                        "country": "Mexico", 
                        "state": "Distrito Federal", 
                        "zip": "06030"
                    }, 
                    "name": "Hospital Torre Medica"
                }, 
                "investigator": {
                    "last_name": "Juan M. Aguilar Aguirre, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Monterrey", 
                        "country": "Mexico", 
                        "state": "Nuevo Leon", 
                        "zip": "64460"
                    }, 
                    "name": "Hospital Universitario, Universidad Autonoma de Nuevo Leon"
                }, 
                "investigator": {
                    "last_name": "Jose G. Garza Leal, M.D.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Mexico"
        }, 
        "number_of_arms": "1", 
        "official_title": "Clinical Study of a Focused Ultrasound Device for Treating Uterine Fibroids and Menorrhagia", 
        "overall_contact": {
            "email": "mlau@mirabilismedica.com", 
            "last_name": "Michael Lau, M.D.", 
            "phone": "425-486-8230", 
            "phone_ext": "203"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Mexico: Federal Commission for Protection Against Health Risks"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Safety of the intervention will be determined by evaluating the incidence and severity of adverse events and adverse device effects.", 
            "measure": "Evaluation of all adverse events encountered", 
            "safety_issue": "Yes", 
            "time_frame": "up to 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01946178"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Preliminary efficacy of the intervention will be determined by evaluating the dimensions and position of nonviable tissue observed in each fibroid specimen via pathological processing following hysterectomy and/or by assessing the non-perfused volume (NPV) observed on post-treatment contrast-enhanced MRI.", 
            "measure": "Observation of tissue response via pathological assessment of fibroid specimens  following hysterectomy and/or post-treatment magnetic resonance imaging (MRI)", 
            "safety_issue": "No", 
            "time_frame": "up to 6 months"
        }, 
        "source": "Mirabilis Medica, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mirabilis Medica, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}